Organovo Holdings has announced a partnership with Autodesk to create the first 3D design software for bioprinting.
A number of projects are starting to work on 3D printing human tissues and body parts, such as a team at the Wake Forest Institute for Regenerative Medicine, who are exploring ways to 3D print a kidney. Organovo Holdings, a manufacturer of functional 3D human tissues for medical research and therapeutic applications, is partnering with researchers at Autodesk, the leader in cloud-based design and engineering software, to create the first 3D design software for bioprinting.
The software will be used to control Organovo’s NovoGen MMX bioprinter, and will be a big step forward in usability and functionality for designing 3D human tissues. It also has the potential to open up bioprinting to a wider group of users. Keith Murphy, chairman and CEO of Organovo, said:
Autodesk is an excellent partner for Organovo in developing new software for 3D bioprinters. This relationship will lead to advances in bioprinting, including both greater flexibility and throughput internally, and the potential long-term ability for customers to design their own 3D tissues for production by Organovo.